Filing Details
- Accession Number:
- 0000950170-24-115726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-18 20:00:04
- Reporting Period:
- 2024-10-16
- Accepted Time:
- 2024-10-18 20:00:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657709 | Chris Francis | C/O Wave Life Sciences Ltd., 733 Concord Ave. Cambridge MA 02138 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2024-10-16 | 79,714 | $14.00 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2024-10-16 | 40,997 | $2.48 | 40,997 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-10-16 | 40,997 | $13.00 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2024-10-16 | 65,625 | $3.14 | 65,625 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-10-16 | 65,625 | $13.75 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2024-10-16 | 22,500 | $2.83 | 22,500 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-10-16 | 22,500 | $13.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (right to buy) | Disposition | 2024-10-16 | 40,997 | $0.00 | 40,997 | $2.48 |
| Ordinary Shares | Share Option (right to buy) | Disposition | 2024-10-16 | 65,625 | $0.00 | 65,625 | $3.14 |
| Ordinary Shares | Share Option (right to buy) | Disposition | 2024-10-16 | 22,500 | $0.00 | 22,500 | $2.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-03-10 | No | 4 | M | Direct | |
| 84,375 | 2032-01-01 | No | 4 | M | Direct | |
| 22,500 | 2032-07-25 | No | 4 | M | Direct |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.
- The share options that were exercised in this reportable transaction were fully vested.
- The share option represented the right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on January 1, 2023, and the remaining shares vest as to an additional 6.25% quarterly thereafter until January 1, 2026.
Billionaire Hedge Funds
